Endocrine
circa 1550 BCE, Ebers Papyrus, Ancient Egypt
Hypoglycemia, a condition involving abnormally low blood sugar, was poorly understood for most of recorded history, with its symptoms long attributed to a variety of unrelated causes. It was not until the late nineteenth and early twentieth centuries that physicians began connecting episodes of weakness, confusion, and collapse to the chemistry of blood glucose. The isolation of insulin in 1921 and subsequent clinical observations transformed understanding of how the body regulated sugar and what happened when that regulation failed.
Historical Narrative
Ancient healers had no concept of blood sugar in any biochemical sense, yet descriptions consistent with hypoglycemic episodes appeared in early medical writings under broader categories of faintness, falling sickness, or humoral imbalance. Egyptian papyri from around 1550 BCE described states of sudden weakness and mental clouding that some later historians speculated might have included hypoglycemic episodes, though the authors attributed such states to disruptions of vital spirits rather than to any measurable bodily substance. Greek physicians, including Hippocrates and his followers, classified sudden collapses and episodes of trembling and confusion within frameworks of phlegm excess or deficiencies of vital heat. No mechanism involving sugar or the pancreas was proposed, and treatment consisted of dietary adjustments believed to restore humoral balance, along with herbal preparations thought to strengthen the vital faculties.
For well over a millennium, medieval European and Islamic physicians inherited and elaborated on Galenic humoral theory without meaningfully advancing the understanding of blood sugar regulation. Ibn Sina, writing in the eleventh century, described conditions of weakness and fainting with great clinical detail but interpreted them entirely within humoral terms. Sweet foods and wines were sometimes recommended for patients experiencing sudden weakness, an empirical approach that occasionally would have been effective without any theoretical understanding of why.
The conceptual breakthrough required the development of biochemistry and endocrinology as disciplines. In the mid-nineteenth century, Claude Bernard conducted landmark experiments demonstrating that the liver produced and released glucose into the bloodstream, establishing that blood sugar was a dynamic and regulated quantity rather than simply a reflection of dietary intake. Bernard's discovery of glycogen and his articulation of the liver's role in glucose metabolism laid essential groundwork. Around the same time, physicians began associating the pancreas with digestive and metabolic functions, though the mechanisms remained obscure.
The transformation in understanding hypoglycemia as a specific clinical entity came dramatically in the early 1920s. The isolation of insulin by Frederick Banting and Charles Best at the University of Toronto in 1921, guided by the laboratory direction of John Macleod and with contributions from James Collip in purification, was intended to treat diabetes. Almost immediately, clinicians working with insulin observed that excessive doses produced profound and dangerous drops in blood sugar, creating for the first time a reliable experimental and clinical model of hypoglycemia. These observations allowed physicians to correlate specific physiological states with measurable glucose levels for the first time.
Seymour Whipple and his colleagues in the 1930s further refined clinical understanding by describing what became known as Whipple's triad, a set of observations linking low blood glucose measurements, characteristic symptoms, and relief following glucose administration, used to identify patients with insulinomas, tumors of the pancreatic islet cells that caused chronic overproduction of insulin. This work established hypoglycemia as a diagnosable clinical syndrome rather than merely an incidental laboratory finding. Throughout the mid-twentieth century, researchers continued mapping the hormonal counterregulatory systems, including glucagon and epinephrine, that the body deployed to resist falling blood sugar, gradually constructing the complex picture of glucose homeostasis that informed all subsequent medical understanding of the condition.
Key Historical Figures
Historical narrative only — this page describes how Hypoglycemia was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.